[1] |
Lippi G, Favaloro EJ, Montagnana M, Manzato F, Guidi GC, Franchini M. Inherited and acquired factor V deficiency. Blood Coagul Fibrinolysis. 2011; 22(3):160-6.
doi: 10.1097/MBC.0b013e3283424883
|
[2] |
Knöbl P, Lechner K. Acquired factor V inhibitors. Baillieres Clin Haematol. 1998; 11(2):305-18.
doi: 10.1016/S0950-3536(98)80050-4
|
[3] |
Lossing TS, Kasper CK, Feinstein DI. Detection of factor VIII inhibitors with the partial thromboplastin time. Blood. 1977; 49(5):793-7.
pmid: 856360
|
[4] |
Ortel TL.Clinical and laboratory manifestations of anti-factor V antibodies. J Lab Clin Med. 1999; 133(4):326-34.
pmid: 10218762
|
[5] |
Ang AL, Kuperan P, Ng CH, Ng HJ. Acquired factor V inhibitor. A problem-based systematic review. Thromb Haemost. 2009; 101(5):852-9.
doi: 10.1160/TH08-11-0767
|
[6] |
Wang X, Qin X, Yu Y, Wang R, Liu X, Ji M, et al. Acquired factor V deficiency in a patient with a urinary tract infection presenting with hematuria followed by multiple hemorrhages with an extremely low level of factor V inhibitor: a case report and review of the literature. Blood Coagul Fibrinolysis. 2017; 28(4):334-41.
|
[7] |
Tracy PB, Eide LL, Bowie EJ, Mann KG. Radioimmunoassay of factor V in human plasma and platelets. Blood. 1982; 60(1):59-63.
pmid: 7082847
|